Class / Patent application number | Description | Number of patent applications / Date published |
424604000 | Heavy metal containing | 33 |
20080206355 | Composition comprising a particulate zinc material, a pyrithione or a polyvalent metal salt of a pyrithione and a synthetic cationic polymer - The present invention relates to a composition comprising a composition comprising an effective amount of a particulate zinc material; an effective amount of a surfactant including a surfactant with an anionic functional group; an effective amount of a pyrithione or a polyvalent metal salt of a pyrithione; from about 0.025% to about 5% by weight of a water soluble or dispersible, cationic, non-crosslinked, conditioning homopolymer having a cationic charge density of from about 2 meq/gm to about 10 meq/gm; and from about 20% to about 95% of an aqueous carrier, by weight of said composition | 08-28-2008 |
20090035385 | COMPOSITIONS INCLUDING IRON - Compositions and methods for prevent, stabilize, reverse or treat disorders related to iron deficiency in a human or other animal. In a first embodiment, the composition includes about 10 mg to about 500 mg of one or more forms of iron, wherein at least one form of iron is an aspartic acid-glycine chelate of iron; and about 5 mg to about 500 mg of one or more forms of an organic acid. In another embodiment, the composition includes about 50 to about 150 mg of one or more forms of iron, wherein at least one form of iron is an aspartic acid-glycine chelate of iron; about 50 to about 250 mg of one or more forms of an organic acid; about 150 to about 250 mg of one or more forms of ascorbic acid; about 0.5 mg to about 1.5 mg vitamin B12; about 50 to about 150 mg intrinsic factor; and about 0.5 mg to about 1.5 mg folic acid. | 02-05-2009 |
20100136132 | LIGNOSULFONATE COMPOSITIONS FOR CONTROL OF PLANT PATHOGENS - The present invention relates to a composition comprising a soluble combination comprising lignosulfonate, a metal salt, and a phosphorous compound selected from the group consisting of phosphorous acid and spontaneously soluble salts thereof, and mixtures thereof. The present invention also relates to the use of such compositions as pesticides. | 06-03-2010 |
20100196501 | SILVER-CONTAINING FOAM STRUCTURE - A method of producing a hydrophilic polyurethane foam structure containing a silver salt, chosen from the group of silver sulphate, silver citrate, silver acetate, silver carbonate, silver lactate and silver phosphate, or a mixture of these salts includes the steps of (a) providing a water phase containing a surfactant, and at least one silver salt, wherein the at least one silver salt is dispersed in the water phase; (b) providing a isocyanate-terminated polyether having functionality of more than (2); (c) mixing the water phase and the isocyanate-terminated polyether, immediately transferring the resulting mixture to a mould whereby a foam structure is obtained; and (d) drying the foam structure until it has a moisture content of at most 10% (wt). The hydrophilic polyurethane foam structure produced by the method and a wound dressing containing the foam structure are also described. | 08-05-2010 |
20100203157 | COMBINATIONS OF PYRIMETHANIL AND SILVER COMPOUNDS - The present invention relates to combinations of pyrimethanil, or a salt thereof, and silver compounds which provide an improved biocidal effect. More particularly, the present invention relates to compositions comprising a combination of pyrimethanil, or a salt thereof, together with one or more silver salts selected from silver acetate, silver alginate, silver azide, silver citrate, silver lactate, silver nitrate, silver sulfate, silver chloride, silver thiocyanate, silver-sodium-hydrogen-zirconium phosphate, silver sulfadiazine, silver cyclohexanediacetic acid and disilver 2,5-dichloro-3,6-dihydroxy-2,5-cyclohexadiene-1,4-dione; in respective proportions to provide a synergistic biocidal effect. Other suitable silver components (II) are products that set silver free using technologies to make it gradually biologically available such as by ion exchange mechanisms such like using zirconium phosphate based ceramics as a reservoir, or silver provided in glass ceramics as reservoir or carrier, or silver provided with zeolites, silica gel or titanium dioxide as a reservoir or an inorganic derivative containing silver, incorporated into a plastic composition for the preparation of moulded, lacquered or painted products, such as an amino resin (e.g. urea-formaldehyde resin, melamine formaldehyde resin . . . ) or a thermoplastic (e.g. a polyester, polyethylene, polyacrylate, pvc . . . ), or provided as nano-silver particles typically with a particle size of 1-1000 nm. Compositions comprising these combinations are useful for the protection of any living or non-living material, such as crops, plants, fruits, seeds, objects made of wood, thatch or the like, biodegradable material and textiles against deterioration due to the action of microorganisms such as bacteria, fungi, yeasts, algae, and the like. | 08-12-2010 |
20100221360 | SILVER-CONTAINING INORGANIC ANTIBACTERIAL - The present invention provides a silver based inorganic antibacterial agent excellent in heat resistance and chemical resistance, lowered in resin coloring and excellent in processability. The present invention has been completed by finding out that problems can be solved by a silver ion-containing zirconium phosphate represented by the following general formula (1) which is produced by a wet synthesis under specific production conditions. | 09-02-2010 |
20100272827 | Method for transdermal iontophoretic delivery of chelated agents - Embodiments provide devices, systems and methods for the transdermal delivery of chelated compounds. One embodiment provides a method for the iontophoretic transdermal delivery of a chelated iron complex for the treatment of anemia. A first patch comprising an active electrode and a chelated iron complex is applied to the skin; a second patch containing an electrode is also applied. An electrical current is then delivered to the skin from the active electrode. The chelated complex is transported across the skin via electromotive force from the current, with the iron being substantially chromogenically unreactive with the skin during transport so that there is little or no tattooing of the skin due to the formation of insoluble oxidative products. The complex is then dissociated by phagocytosis or related process to release the iron where it may be bound by transferrin or ferritin and carried to other sites for storage or metabolic use. | 10-28-2010 |
20100272828 | SILVER-CONTAINING INORGANIC ANTIBACTERIAL - The present invention is completed by finding that a silver ion-containing zirconium phosphate represented by the following formula (1) is excellent in heat resistance and chemical resistance, low in resin coloring and excellent in processability. | 10-28-2010 |
20110052720 | COMPOSITIONS FOR THE CONTROL OF PLANT PATHOGENS AND FOR USE AS PLANT FERTILIZER - The present invention relates to a composition comprising a metal compound, a lignosulfonate and phosphorous acid and/or a salt and/or a hydrate and/or an ester thereof and its use as fungicide, bactericide or fertilizer and its use in preventing the formation of a metal phosphite precipitate in an aqueous composition. The composition is preferably an aqueous composition comprising 0.1 wt. % to 40 wt. % of dry matter, calculated on the total weight of the aqueous composition. The present invention also relates to a process for preparing the aqueous composition. | 03-03-2011 |
20110142958 | COMPOSITION AND METHOD FOR CONTROL OF PLANT PATHOGENIC BACTERIA AND ENDOPHYTIC MICROORGANISMS USING COPPER PHOSPHITE AND NUTRIENT-HALO-PHOSPHITE COMPOUNDS - The present disclosure is directed toward a composition and method of treating and preventing infection of pathogenic microorganisms and endopyhtic microorganisms in a plant through the use of phosphite compositions. | 06-16-2011 |
20110159106 | DERMATOLOGICAL COMPOSITIONS CONTAINING AN ASSOCIATION OF PEROXIDIZED LIPIDS AND ZINC, AND USES THEREOF IN PARTICULAR IN THE TREATMENT OF HERPES - A dermatological composition containing an association of peroxidized lipids; and zinc in mineral form or zinc compound compatible with dermatological use, formulated for topical application on the skin or the mucous membranes, is disclosed compatible with dermatological use. The composition may be used as a medical device to assist in healing and/or reconstitution of a damaged epidermis and/or to act as an analgesic agent on the skin or the mucous membranes, in particular in the treatment of the symptoms of herpes, pruritus, itching, irritations, eczema, burns, and most particularly in the treatment of labial or genital herpes. | 06-30-2011 |
20110223258 | Ferric Phosphate Based Composition, the Preparation and Use Thereof - The invention deals with an ferric phosphate based composition, in order to obtain which 100 mass fractions of orthophosphoric acid, 10-20 mass fractions of iron(III) oxide, 5-10 mass fractions of powdery aluminium oxide and 100 mass fractions of water are mixed, whereas the reaction takes place within a temperature range of 60-70° C. and at least one nanopowder from among silver, copper or flint is added to the mixture in the amount of 0.5 mass fractions, The ferric phosphate based compositions can be used for the bio- and fire protection of timber, as an antibacterial disinfectant, as well as a rust converter for the rust-inhibiting of metals. | 09-15-2011 |
20120009273 | KIT OF PHARMACEUTICAL FORMULATIONS CHARACTERIZED BY THE PRESENCE OF MOLECULAR OXYGEN - An array of pharmaceutical formulations characterized by the presence of molecular oxygen comprising four elements which, in combination, furnish benefits for the health of patients with HIV AIDS: (i) weight increase of the patient; (ii) increase of appetite; (iii) reduction of diarrhea; (iv) reduction of the wasting syndrome; (v) increase of stability of mood; (vi) increase of muscular mass. (vii) decrease of opportunistic diseases, in particular infections caused by Candida, herpes virus, cytomegalovirus, Kaposi's sarcoma; (viii) prolongation of the period wherein the patient does not require to take antiretrovirals; (ix) increase of acceptance of pharmacological treatment; x. reduction of gastritis, nausea or vomiting, headache; (xi) reduction of cases with anemia or thrombocytopenia; and (xii) a change in the phase of the disease in the patient. | 01-12-2012 |
20120009274 | FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER - The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi. | 01-12-2012 |
20120034312 | 4-ISOPROPYL-3-METHYLPHENOL FOR THE TREATMENT OF INFLAMMATION - This invention relates to the use of 4-isopropyl-3-methylphenol (IPMP) for combating inflammation and compositions comprising IPMP for such use. | 02-09-2012 |
20120070509 | SILVER-BASED INORGANIC ANTIMICROBIAL AGENT, METHOD FOR PREPARING THE SAME AND ANTIMICROBIAL PRODUCT - Disclosed is a silver-based inorganic antimicrobial agent which exhibits superior heat resistance, chemical resistance, processability and long-lasting waterproofness. | 03-22-2012 |
20120114764 | MULTIFUNCTIONAL PRODUCE WASH - A produce wash is provided that significantly reduces the amount of chlorine used in treating produce and inhibits the growth of micro-organisms on pre-harvest and post-harvest produce. A method of using the produce wash extends the shelf life of harvested produce. | 05-10-2012 |
20120141597 | FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER - The present invention relates to the use of hydrazone compounds and copper for controlling the growth of fungi. | 06-07-2012 |
20120213862 | Negative Ion-Releasing Silica Compositions and Methods of Preparing and Using the Same - Negative ion-releasing silica compositions and methods for their preparation and use are described herein. The compositions include silicon dioxide and gadolinium. Further described herein are products including the compositions. | 08-23-2012 |
20120263798 | Body Aqua - The invention provides an entire line of deliciously flavored bottled water beverages with each flavor offering comprised of vitamins, minerals and nutritional supplements for fortifying the body. A sugar free, carbohydrate free and low sodium formula, Body Aqua features natural flavoring and natural sweeteners such as Stevia™. The Body Aqua product line contains ten varieties, with each formula designed to target a specific area of the body and promote overall health. | 10-18-2012 |
20130011489 | ANTI-FUNGAL COMPOSITIONS AND ASSOCIATED METHODS - The present disclosure provides methods and compositions for treating fungal diseases of plants. In one embodiment, an anti-fungal aqueous composition can comprise: a nitrogen source material having a total nitrogen content in an amount of about 0.1 wt % to about 0.5 wt % of the total weight of the composition, a phosphate source material having total phosphate content in an amount of about 0.05 wt % to about 0.15 wt % of the total weight of the composition, a potassium source material with a soluble potash content in an amount of about 0.05 wt % to about 0.15 wt % of the total weight of the composition, and a sulfur source material in an amount of about 0.005 wt % to about 0.02 wt % of the total weight of the composition. | 01-10-2013 |
20130273173 | SOLID DRUG DELIVERY APPARATUS, FORMULATIONS AND METHODS OF USE - Embodiments provide apparatus and methods for delivering solid form medications such as pellets to various locations in the body. One embodiment provides an apparatus for in vivo delivery of medication pellets comprising a housing including a port, a pellet-containing belt disposed in the housing, and a mechanism for transferring the pellets from the belt to a delivery site (DS) outside the housing. Each pellet contains a dose of drug to treat a medical condition. An elongate member is coupled to the housing and includes a lumen for pellet delivery, a proximal end coupled to the port and a distal end positioned at the DS. The pellet can be delivered to the DS at regular intervals or responsive to a detected biological event. Embodiments of the invention are particularly useful for delivering medication to treat a medical condition over an extended period without requiring a patient to take external medication. | 10-17-2013 |
20140141096 | Cross-linked collagen comprising an antifungal agent - The disclosure describes collagen constructs comprising antifungal agents, preferably, copper, and related methods. | 05-22-2014 |
20140234437 | IRON SUPPLEMENT COMPOSITION - In one of its aspects, the present invention provides a composition comprising: (i) a non-encapsulated iron salt, and (ii) a carrier comprising digestible edible oil that is a liquid at 20° C. This composition advantageously provides iron in a form that is easily administered to an infant or adult. When taken directly by mouth or added to food or infant formula, the composition has a desirably bland flavor and is easy to consume. Moreover, the high density of iron per unit volume of the composition results in a minimal volume of liquid to be administered. This makes the composition relatively innocuous and easy for infants to consume. Related aspects of the present invention are also described—e.g., uses, articles of manufacture and the like. | 08-21-2014 |
20140242187 | Iron-Fiber Composition, Preparation and Uses Thereof - Compositions comprising ferrous and/or ferric iron compounds and fiber in a complex, methods for preparing such compositions of matter, and the use thereof for treatment of adsorbing certain accessible targets in the gastrointestinal tract and in an extracorporeal system, are provided herein. | 08-28-2014 |
20150017256 | CONDENSED IRON (III) PHOSPHATE - Method for producing condensed iron (III) phosphate, in which a) an aqueous solution containing Fe2+ ions is produced, in which oxidic iron (II), iron (III) or mixed iron (II, III) compounds selected from among hydroxides, oxides, oxide hydroxides, oxide hydrates, carbonates and hydroxide carbonates are introduced together with elementary iron into an aqueous medium containing phosphoric acid, wherein Fe2+ ions are dissolved and Fe3+ with elementary Fe (in a comproportionation reaction) is reacted to dissolved Fe2+, b) separating solid material from the phosphoric acid aqueous Fe2+ solution, c) adding an oxidizer to the phosphoric acid aqueous Fe2+ solution to oxidise iron (II) in the solution, d) adding polyphosphate in the form of polyphosphoric acid or salts thereof as solid material or aqueous solution after completion of the oxidation reaction to precipitate condensed iron (III) phosphate, and e) separating the precipitated condensed iron (III) phosphate solution and resulting product. | 01-15-2015 |
20150290128 | GUMMY COMPOSITIONS FOR NUTRITIONAL SUPPLEMENTATION - A method for treating a prenatal, pregnant or breastfeeding patient for a disease, condition or disorder that is associated with a nutritional deficiency in the patient comprising administering at least one gummy composition to a patient. The gummy composition comprises an effective amount of vitamin A, vitamin B | 10-15-2015 |
20150366907 | METHODS OF TREATING IRON DEFICIENCY WITH SOLUBLE FERRIC PYROPHOSPHATE - The invention provides for methods of treating iron deficiency and methods of reducing or eliminating the dose of erythropoiesis stimulating agent for increasing or maintaining hemoglobin levels in the target range in a subject suffering from anemia comprising administering soluble ferric pyrophosphate in an amount effective to maintain or increase Hgb levels in the subject. | 12-24-2015 |
20150373987 | HETEROPOLYOXOMETALATES - The present invention relates to the use of heteropolyoxometalates for disinfecting purposes and in antimicrobial surfaces, paints or coatings and intermediates for their preparation. | 12-31-2015 |
20160015630 | SPRAYABLE OXYGENATED SALINE COMPOSITION AND METHOD FOR TREATING NASAL CONGESTION, ALLERGY, DRYNESS, EYE IRRITATION, THROAT IRRITATION, WOUNDS, AND SKIN AS APPLIED TO HUMAN TISSUES - An oxygenated saline composition is provided comprising stabilized oxygen, sodium chloride (aqueous saline solution), and optionally one or more homeopathic components. The stabilized oxygen can include quad-atomic oxygen. Also provided is a method for treating, reducing or preventing nasal and/or sinus congestion, allergy, dryness, throat irritation, skin irritation, wounds, or eye irritation comprising administering to an individual in need thereof an effective amount of an oxygenated saline composition comprising stabilized oxygen, aqueous saline solution, and optionally one or more homeopathic components, wherein the composition is administered by intranasal spraying, throat spray, skin spray, sublingually, or by eye drops. | 01-21-2016 |
20160029641 | ANTIMICROBIAL CHEMICAL COMPOSITIONS - Antimicrobial chemical compositions comprise an aluminum phosphate (AlP) solid dispersed within a binding polymer, wherein one or more bioactive materials are disposed within AlP forming a bioactive-AlP complex. The complex may comprise the bioactive material chemically bonded with the AlP, physically combined with the AlP, or a combination of both. The complex may be formed according to precipitation, condensation and sol-gel methods of forming. The complex is engineered to provide a controlled delivery of the bioactive material or a constituent thereof upon exposure to moisture to give a desired level of antimicrobial resistance to a film or composite formed from the composition of at least about 30 μg/m | 02-04-2016 |
20160050961 | FOOD SUPPLEMENT FOR PEOPLE WITH DOWN SYNDROME, AUTISM SPECTRUM DISORDER AND/OR ATTENTION DEFICIT DISORDER WITH OR WITHOUT HYPERACTIVITY - The present invention describes a food supplement comprising isomaltulose, milk serum protein concentrate, linseed, milk serum mineral complex, short chain fructooligosacharides, lactoferrin, and vitamin B6. This food supplement was developed for use as support in the nutritional therapy in people suffering from Trisomy 21, Autism Spectrum Disorders and/or Attention Deficit Disorder with or without Hyperactivity. | 02-25-2016 |
20160250254 | METHODS OF REDUCING DOSES OF ERYTHROPOIETIN STIMULATING AGENTS IN HYPORESPONSIVE PATIENTS | 09-01-2016 |